Navigation Links
FDA Panel OKs 3 New Flu Strains for Next Year's Vaccine
Date:2/21/2008

et inoculated. The reason: The vaccine still offers partial protection and can reduce the risk of flu-related complications.

An estimated 5 percent to 20 percent of the U.S. population suffers from the flu each year. More than 200,000 people are hospitalized from flu complications, and about 36,000 people die from the disease. Some people, such as older individuals, young children, and people with certain health conditions (such as asthma, diabetes or heart disease), are at high risk for serious flu complications, according to the CDC.

More information

The U.S. Centers for Disease Control and Prevention has more on the flu and the flu vaccine.



SOURCES: Peter C. Welch, M.D., infectious disease expert, Northern Westchester Hospital, Mt. Kisco, N.Y.; Dow Jones Newswire; Feb. 22, 2008, Morbidity and Mortality Weekly Report, U.S. Centers for Disease Control and Prevention


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. VA Creating Advisory Panel on Rural Health
2. Penn childhood obesity researchers panelists at AAAS Town Hall Event
3. Advanced Life Sciences to Participate in Antibiotics Expert Panel at the 10th Annual BIO CEO & Investor Conference
4. Harm of Abstinence-Only Programs in U.S. and Abroad Subject of Panel Discussion at Two Maine College Campuses
5. Decongestant in OTC Cold Remedies Effective: FDA Panel
6. FDA Panel Finds OTC Cold Remedies Effective
7. FDA Advisory Panel Finds Hologics Adiana(R) Permanent Contraception Approvable
8. FDA Panel Considering Over-the-Counter Statin
9. FDA Panel to Consider Over-the-Counter Statin
10. NIH panel seeks to dispel stigma associated with fecal and urinary incontinence
11. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Panel OKs 3 New Flu Strains for Next Year's Vaccine
FDA Panel OKs 3 New Flu Strains for Next Year's Vaccine
(Date:11/25/2009)...PRNewswire-FirstCall/-- OnyxPharmaceuticals,Inc.(...twoinvestoreventsinDecember: ,, ASHBriefing ..., Principalinvestigatorswilldiscussdatapresenta...orymultiplemyeloma,asfeaturedatthe51stAmericanSoci...wOrleans,LA.Theteleconferencewillbeginat9:00a.m.CT...
(Date:11/25/2009)...RNewswire/--Thanksgivingmealswillbedeliveredtoappr...hareathankstoFaithInAction/VolunteerActionforAging...onofSCANHealthPlan.Formorethan17yearstheseorganiza...ThanksgivingmealstoseniorsinneedinLongBeach,Lakewo...ngcities. ,, "Ourwarmholidaymealsaredeliveredto...
(Date:11/25/2009)...swire/--TheBayAreaAirQualityManagementDistrictisis...r Alert forThursday,November26,2009whichbansb...,bothindoorsandoutdoors. ,, "Cold,stillweatherw...ckBroadbent,executiveofficeroftheAirDistrict."We,r...ighborsandfellowcommunitymembersthisThanksgiving,a...
(Date:11/25/2009)... of a statistically significant survival benefit f...en receptor (ER)-positive tumors had high levels o...lpha S118-P), according to a brief communication p... National Cancer Institute . , Approximately 50%...Preclinical studies have shown that ER-alpha S118-...
(Date:11/25/2009)...o short to draw definite conclusions, experts say,...) -- In diabetic patients with blocked coronary ar...mes at one year whether patients undergo bypass su...chers report. , Bypass surgery has been the sta...y artery disease. However, less invasive approache...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
... 4 Acclarent, Inc., the pioneer of Balloon Sinup...f chronic sinusitis, announced today that the U.S....umber 7,500,971, entitled "Devices, Systems and Me...ds for treating a paranasal sinus ostium, such as ...
...Calm; Take Commonsense Steps to Prevent Spreading ... G. Rendell today announced Pennsylvania,s first l...ar-old man from Montgomery County. , , "Now that...spread of the flu," said Governor Rendell. "Our De...
... Identifying one of the processes that plays a ro...on could one day lead to better vaccines and possi...earchers at Baylor College of Medicine and Texas C...sor of pathology at BCM, along with his research t...
... The American Society for Aesthetic Plastic Surge...inners , New York, NY (Vo... magazine, CNN and ABC News 20/20 are among winner...from over 125 entries, this year,s winners will be...
... The evolution of liposuction will be discussed b...rican Society for Aesthetic Plastic Surgery (ASAPS...ention Center May 2-7, 2009. , ...iety for Aesthetic Plastic Surgery (ASAPS), being ...
...esterol, so study suggests better screening for hy...ews) -- While untreated hypertension in any child ...ous enlargement or thickening of one chamber of th...ents under age 21, researchers from Johns Hopkins ...
Other Medicine News:Health News:Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies 2Health News:Governor Rendell Announces Pennsylvania's First Confirmed Case of 2009 A/H1N1 Flu 2Health News:Governor Rendell Announces Pennsylvania's First Confirmed Case of 2009 A/H1N1 Flu 3Health News:Process controlling T cell growth and production identified 2Health News:Aesthetic Society Awards Journalists' Commitment To Patient Education 2Health News:Aesthetic Society Awards Journalists' Commitment To Patient Education 3Health News:Liposuction Turns 20 2Health News:Liposuction Turns 20 3Health News:Liposuction Turns 20 4Health News:Black Youths With High BP May Face Elevated Heart Risks 2
(Date:11/25/2009)...ire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedi...mallydisruptivesurgicaltreatmentsforthespine,annou...ember30,2009,at5:30p.m.ET/2:30p.m.PT.Theconference...tfortheCompany,sproductsandwillincludecommentsfrom....Thedial-innumbersare1-877-407-4018fordomesticcall...
(Date:11/25/2009)...JOHANNESBURG,November25/PRNewswire/--,iThembaPharm...edtoday,thattheyhavesignedacollaborativeagreementt...s,sworldclasscomputationalchemistryandleaddiscover...ontoprovidemedicinaland,syntheticchemistrysupportt...ntnetwork.iThembaPharmaceuticalsandPyxisDiscovery,...
(Date:11/24/2009)...swire/-- ,, WHAT:RomHoubens,aBelgianmanthoughtt...asactuallyfullyconsciousandawakeduringthattimeandw...xEyeMaxwasfeaturedinthesegmenttoillustratehowpeopl...ommunication. ,, WHEN:GoodMorningAmerica-- Tues...h.com ,, WHO:RomHoubenswasanengineeringstud...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 1GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 2GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 3Article Now Available 3A Are Special Orders Draining Your Budgets 3F 53715 1Article Now Available 3A Are Special Orders Draining Your Budgets 3F 53715 2Article Now Available 3A Are Special Orders Draining Your Budgets 3F 53715 3Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 1Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 2Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 3Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 4
...ONDON, Oct. 23 Morria Biopharmaceuticals Plc, a,b...t of novel,anti-inflammatory drugs, today announce...RX-4 in 16 patients suffering from allergic rhinit...le blind clinical trial is the,first of two module...y in,AR. MRX-4 is nasally administered as a single...
...ASHINGTON, Oct. 22 Today, the American,Society of...ical Oncology,(ASCO) have released an updated join...ng agents (ESAs), a class of drugs that stimulate,...o treat,chemotherapy-related anemia., "One goal o...e most,up-to-date evidence from high-quality studi...
Other Medicine Technology:Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis 2ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 2ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 3
BD Visitec Vitreoretinal Cannulas
BD Beaver Lamellar Blades
BD Optimum Stab Blades and Knives
BD Visitec Nucleus Rotator
Medicine Products: